(Q51381188)
Statements
Safety, tolerability and pharmacokinetics of single escalating doses of indacaterol, a once-daily beta2-agonist bronchodilator, in subjects with COPD (English)
S Pascoe
C Reynolds
W Pleskow
S Perry
A Hmissi
G Kaiser